Procter & Gamble vs Honeywell
Global consumer staples giant with diverse household brands vs Diversified industrial technology group with aerospace and building businesses. Which is the better buy for your portfolio in July 2026? Plain-English answer below.
Procter & Gamble prices its consumer staples brands at premiums that millions of households accept without thinking while Honeywell sells automation, safety, and aerospace solutions to industrial and commercial customers who buy on performance, not habit. Both companies are large-cap industrials-adjacent businesses with decades of dividend growth and pricing power, but their end-market dynamics differ sharply. The Procter & Gamble vs Honeywell comparison reveals how brand loyalty economics and industrial technology value propositions translate into distinctly different earnings growth trajectories.
Procter & Gamble prices its consumer staples brands at premiums that millions of households accept without thinking while Honeywell sells automation, safety, and aerospace solutions to industrial and ...
Why It’s Moving
PG stays in the spotlight as analysts stick with a cautiously upbeat view on the consumer-staples giant.
- Analyst sentiment remains constructive, with consensus data showing more Buy ratings than Sell ratings and a median-to-average target range that still points to modest upside for Procter & Gamble.
- The stock’s narrative is being driven more by steady consumer-staples positioning than by a fresh company-specific catalyst, which keeps PG in favor as a defensive name when investors want stability.
- Recent analyst updates have not shifted the story dramatically, suggesting traders are treating PG as a reliable, low-volatility holding rather than a high-growth momentum trade.
Honeywell slips as analysts flag limited near-term upside amid restructuring uncertainty
- Investors are weighing Honeywell’s ongoing portfolio reshaping, including the aerospace separation and the planned Quantum/Quantinuum listing, which could unlock value but also adds execution risk over the near term.
- Analysts have turned more cautious on the name in recent weeks, with some trimming ratings and targets as they question whether the restructuring will translate into faster growth soon enough.
- The stock is being pressured by broader industrial-sector jitters and concerns around demand in automation and aerospace, keeping near-term sentiment muted even as the long-term story stays intact.
PG stays in the spotlight as analysts stick with a cautiously upbeat view on the consumer-staples giant.
- Analyst sentiment remains constructive, with consensus data showing more Buy ratings than Sell ratings and a median-to-average target range that still points to modest upside for Procter & Gamble.
- The stock’s narrative is being driven more by steady consumer-staples positioning than by a fresh company-specific catalyst, which keeps PG in favor as a defensive name when investors want stability.
- Recent analyst updates have not shifted the story dramatically, suggesting traders are treating PG as a reliable, low-volatility holding rather than a high-growth momentum trade.
Honeywell slips as analysts flag limited near-term upside amid restructuring uncertainty
- Investors are weighing Honeywell’s ongoing portfolio reshaping, including the aerospace separation and the planned Quantum/Quantinuum listing, which could unlock value but also adds execution risk over the near term.
- Analysts have turned more cautious on the name in recent weeks, with some trimming ratings and targets as they question whether the restructuring will translate into faster growth soon enough.
- The stock is being pressured by broader industrial-sector jitters and concerns around demand in automation and aerospace, keeping near-term sentiment muted even as the long-term story stays intact.
Investment Analysis
Pros
- Procter & Gamble has a strong global presence with a diversified portfolio including beauty, grooming, healthcare, and household care segments.
- Analysts maintain a consensus 'Buy' rating with an average price target suggesting a potential 19-20% upside over the next year.
- The company has consistent dividend payments, making it attractive for income-focused investors seeking steady returns.
Considerations
- Recent insider selling has raised concerns about future performance and may indicate cautious sentiment from key executives.
- The stock currently trades at a relatively high price-to-earnings ratio compared to its earnings potential, suggesting possible overvaluation.
- Procter & Gamble’s stock price has shown volatility with fluctuations between approximately $147 and $180 over the last year, which might deter risk-averse investors.
Honeywell
HON
Pros
- Honeywell reported robust Q2 2025 earnings that exceeded estimates and raised its adjusted EPS guidance for the year.
- The company’s aerospace division is a key growth driver, considered undervalued by analysts and poised for higher valuation multiples.
- Recent strategic moves, including acquisitions and a planned three-way corporate split, aim to unlock value and enhance shareholder returns.
Considerations
- Honeywell’s stock trades at a higher price-to-book ratio relative to sector averages, implying a premium valuation that may limit upside.
- The company operates in cyclical industrial sectors, exposing it to macroeconomic fluctuations that could affect performance.
- Execution risks remain around the announced corporate restructuring and the integration of recent acquisitions, which could impact near-term results.
Procter & Gamble (PG) Next Earnings Date
The next earnings date for PG is July 29, 2026, based on the company’s scheduled fourth-quarter fiscal 2026 results announcement. The report will cover fiscal Q4 2026. The timing is consistent with P&G’s typical late-July earnings pattern.
Honeywell (HON) Next Earnings Date
Honeywell International (HON) has not yet confirmed its next earnings date, but the market estimate is July 23, 2026 based on its historical reporting pattern. The upcoming release would cover Q2 2026 results. If the company does not announce a specific date, investors should treat that estimate as the most likely timing.
Procter & Gamble (PG) Next Earnings Date
The next earnings date for PG is July 29, 2026, based on the company’s scheduled fourth-quarter fiscal 2026 results announcement. The report will cover fiscal Q4 2026. The timing is consistent with P&G’s typical late-July earnings pattern.
Honeywell (HON) Next Earnings Date
Honeywell International (HON) has not yet confirmed its next earnings date, but the market estimate is July 23, 2026 based on its historical reporting pattern. The upcoming release would cover Q2 2026 results. If the company does not announce a specific date, investors should treat that estimate as the most likely timing.
Buy PG or HON in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
